Literature DB >> 17108228

Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods.

Elena Y Rykova1, Winfried Wunsche, Olga E Brizgunova, Tatyana E Skvortsova, Svetlana N Tamkovich, Ilija S Senin, Pavel P Laktionov, Georg Sczakiel, Valentin V Vlassov.   

Abstract

Circulating RNA (cirRNA) was isolated from plasma and cell surface-bound fractions of blood of healthy women and breast cancer patients. RNA samples were DNase treated and quantified by a SYBR Green II assay. Concentrations of RNA sequences of GAPDH, Ki-67 mRNA, and 18S rRNA were measured by real-time quantitative PCR (RT-qPCR) after reverse transcription with random hexamer primers. The obtained data spread over three orders of magnitude for GAPDH and Ki-67 mRNA signals and two orders of magnitude for the copy number of 18S rRNA in blood fractions in both groups. In blood of healthy donors, no correlation was found between the copy number of GAPDH, Ki-67 mRNA, and 18S rRNA and RNA concentrations measured by the SYBR Green II assay. Within the group of breast cancer patients, the concentration GAPDH and Ki-67 mRNA correlated with the concentration of total RNA only in the cell surface-bound fraction; whereas the concentration of 18S rRNA correlated with total RNA in both, the cell surface-bound fraction and blood. The copy number of Ki-67 mRNA correlated with copy numbers of GAPDH mRNA in all fractions of cirRNA of healthy donors and breast cancer patients. A correlation between copy numbers of Ki-67 mRNA and 18S rRNA was found only in cell surface-bound fraction of breast cancer patients. The data described here demonstrate the necessity of searching for more suitable RNA markers in order to estimate total cirRNA concentrations by RT-qPCR, although mRNA of GAPDH could be used for normalization of the level of cancer-specific mRNA among patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108228     DOI: 10.1196/annals.1368.044

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Authors:  S B Krintel; C Dehlendorff; M L Hetland; K Hørslev-Petersen; K K Andersen; P Junker; J Pødenphant; T Ellingsen; P Ahlquist; H M Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; H C Horn; A Jørgensen; J Raun; C G Ammitzbøll; M Østergaard; K Stengaard-Pedersen; J S Johansen
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

2.  Template-dependent multiple displacement amplification for profiling human circulating RNA.

Authors:  Weihua Wang; Yi Ren; Yang Lu; Yuan Xu; Seth D Crosby; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  Biotechniques       Date:  2017-07-01       Impact factor: 1.993

3.  Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

Authors:  Iris Lavon; Miri Refael; Bracha Zelikovitch; Edna Shalom; Tali Siegal
Journal:  Neuro Oncol       Date:  2010-02-01       Impact factor: 12.300

4.  MicroRNA expression profiles of whole blood in lung adenocarcinoma.

Authors:  Santosh K Patnaik; Sai Yendamuri; Eric Kannisto; John C Kucharczuk; Sunil Singhal; Anil Vachani
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

5.  Lowering the quantification limit of the QubitTM RNA HS assay using RNA spike-in.

Authors:  Xin Li; Iddo Z Ben-Dov; Maurizio Mauro; Zev Williams
Journal:  BMC Mol Biol       Date:  2015-05-06       Impact factor: 2.946

6.  Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats.

Authors:  Mirco Castoldi; Claus Kordes; Iris Sawitza; Dieter Häussinger
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

7.  Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation.

Authors:  Wei Cao; Dan Zhou; Weiwei Tang; Hanxiang An; Yun Zhang
Journal:  PeerJ       Date:  2019-06-18       Impact factor: 2.984

8.  Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer.

Authors:  Peter Brian Gahan
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.